Bronchiolitis obliterans is a rare but well-recognised bronchopulmonary manifestation associated with IBD. This case report is unusual in the severity of the respiratory disease, requiring referral for consideration of lung transplantation with further implications in the clinical management of severe UC. We have reviewed the literature concerning bronchopulmonary manifestations of IBD and discuss the difficulties in distinguishing between a primary manifestation associated with IBD and a side-effect of drug therapy.
Get full access to this article
View all access options for this article.
References
1.
HaralambouGASTeirsteinJGilPresentDH.Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine. Mt Sinai J Med 2001; 68(6):384–8.
2.
ReinosoMAKWSchroederPisaniRJ.Lung disease associated with orally administered mesalamine for ulcerative colitis. Chest 1992; 101(5):1469–71.
EkbomACGHelmickMZackLHolmberg,Adami HO. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology 1992; 103(3):954–60.
5.
PerssonPGOBernellCELeijonmarckBYFarahmandGHellersSurvivalAhlbom A.mortalitycause-specific in inflammatory bowel disease: a population-based cohort study. Gastroenterology 1996; 110(5):1339–45.
6.
TzanakisNMSamiouDBourosJMouzasEKouroumalisSiafakasNM.Small airways function in patients with inflammatory bowel disease. Am J Respir Crit Care Med 1998; 157(2):382–6.
7.
AdenisAJFColombelLecouffeP Increased pulmonary and intestinal permeability in Crohn's disease. Gut 1992; 33(5):678–82.
8.
HeatleyRVPThomasEJProkipchukJGauldieDJSieniewiczBienenstockJ. Pulmonary function abnormalities in patients with inflammatory bowel disease. Q J Med 1982; 51(203):241–50.
9.
CamusPFPiardTAshcroftAAGalColbyTV.The lung in inflammatory bowel disease. Medicine (Baltimore) 1993; 72(3):151–83.
10.
MyersJLPathologic manifestations of bronchiolitisColby TV.bronchiolitisconstrictivepneumoniacryptogenic organizing, and diffuse panbronchiolitis. Clin Chest Med 1993; 14(4):611–22.
11.
ColbyTV.Bronchiolitis. Pathologic considerations. Am J Clin Pathol 1998; 109(1):101–9.
12.
RosenbergMEGMVercellottiDCSnoverDHurdMcGlaveP. Bronchiolitis obliterans after bone marrow transplantation. Am J Hematol 1985; 18(3):325–8.
13.
PazHLPCrilleyAPatchefskyRLSchiffmanBrodskyI. Bronchiolitis obliterans after autologous bone marrow transplantation. Chest 1992; 101(3):775–8.
14.
EplerGR.Bronchiolitis obliterans and airways obstruction associated with graft–versus–host disease. Clin Chest Med 1988; 9(4):551–6.
15.
Murphy KC,Atkins CJ, Offer RC, Hogg JC, Stein HB. Obliterative bronchiolitis in two rheumatoid arthritis patients treated with penicillamine. Arthritis Rheum 1981; 24(3):557–60.
16.
RobinsonBWSterrettG. Bronchiolitis obliterans associated with polyarteritis nodosa. Chest 1992; 102(1):309–11.
17.
KellerCAPTCagleRWBrownGNoonBronchiolitis obliterans in recipients of singleFrost AE., double, and heart–lung transplantation. Chest 1995; 107(4):973–80.
18.
GlanvilleARJCBaldwinCMBurkeJTheodoreRobinED.Obliterative bronchiolitis after heart–lung transplantation: apparent arrest by augmented immunosuppression. Ann Intern Med 1987; 107(3):300–4.
19.
Mahadeva R,Walsh G, Flower CD, Shneerson JM. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J 2000; 15(1):41–8.
20.
ParrySDCBarbatzasETPeelSulphasalazineBarton JR. and lung toxicity. Eur Respir J 2002; 19(4):756–64.
21.
WilliamsTLEidusFibrosing alveolitisThomas P.obliteransbronchiolitis, and sulfasalazine therapy. Chest 1982; 81(6):766–8.
22.
BenturLJLachterKorenI Severe pulmonary disease in association with Crohn's disease in a 13-year-old girl. Pediatr Pulmonol 2000; 29(2):151–4.
23.
SarroujBJDJZampinoCilursuAM.Pericarditis as the initial manifestation of inflammatory bowel disease. Chest 1994; 106(6):1911–2.
24.
PatwardhanRVRJHeilpernACBrewsterDarrahJJ.Pleuropericarditis: an extraintestinal complication of inflammatory bowel disease. Report of three cases and review of literature. Arch Intern Med 1983; 143(1):94–6.
25.
FoucherPMBiourBlayacJP Drugs that may injure the respiratory system. Eur Respir J 1997; 10(2):265–79.
SwinburnCRGJJacksonICobdenTAshcroftGNMorrittCorrisPA.Bronchiolitis obliterans organising pneumonia in a patient with ulcerative colitis. Thorax 1988; 43(9):735–6.
31.
SearlesGMcKendryRJ.Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature. J Rheumatol 1987; 14(6):1164–71.
32.
EganLJSandbornWJ.Methotrexate for inflammatory bowel disease: pharmacology and preliminary results. Mayo Clin Proc 1996; 71(1):69–80.
33.
SteinRBHanauerSB.Comparative tolerability of treatments for inflammatory bowel disease. Drug Saf 2000; 23(5):429–48.
34.
WarrisAABjorneklettGaustadP. Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med 2001; 344(14):1099–100.
35.
SpiraARGrossmanBalterM. Large airway disease associated with inflammatory bowel disease. Chest 1998; 113(6):1723–6.
EzriTSKunichezkyAElirazDSorokerDHalperinSchattnerA. Bronchiolitis obliterans–current concepts. Q J Med 1994; 87(1):1–10.
39.
DusmetMJMaurerTWintonKestenS. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant 1996; 15(9):948–54.
40.
EgererGMWitzensSpaethA Successful treatment of bronchiolitis obliterans organizing pneumonia with low-dose methotrexate in a patient with Hodgkin's disease. Oncology 2002; 61(1):23–7.
41.
KestenSCChaparroMScavuzzoGutierrezC. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome. J Heart Lung Transplant 1997; 16(9):905–12.
42.
KoinumaDMMikiEbinaM Successful treatment of a case with rapidly progressive Bronchiolitis obliterans organizing pneumonia (BOOP) using cyclosporin A and corticosteroid. Intern Med 2002; 41(1):26–9.
43.
EplerGRTVColbyTCMcLoudCBCarringtonGaenslerEA.Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985; 312(3):152–8.
